Compliance with dosing guidelines in patients with chronic kidney disease.
about
Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKDFactors associated with ordering laboratory monitoring of high-risk medications.Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient.A pharmacy medication alert system based on renal function in older patients.Audit of renal drug dosing: comparison of 2 methods and evaluation of pharmacists' knowledge, attitudes, and behaviourUse of Renally Inappropriate Medications in Older Veterans: A National StudyOptimising drug prescribing and dispensing in subjects at risk for drug errors due to renal impairment: improving drug safety in primary healthcare by low eGFR alerts.Appropriateness of drug dose and frequency in patients with renal dysfunction in a tertiary care hospital: A cross-sectional studyComputerized clinical decision support during medication ordering for long-term care residents with renal insufficiencyRenal Drug Dosing. Effectiveness of Outpatient Pharmacist-Based vs. Prescriber-Based Clinical Decision Support Systems.Using the diffusion of innovations theory to assess socio-technical factors in planning the implementation of an electronic health record alert across multiple primary care clinics.Renal profiles of anticoagulants.Estimating renal function to reduce the risk of adverse drug reactions.Pharmacist-driven renal medication dosing intervention in a primary care patient-centered medical home.Influence of kidney disease on drug disposition: An assessment of industry studies submitted to the FDA for new chemical entities 1999-2010.Adherence with renal dosing recommendations in outpatients undergoing haemodialysis.Inappropriate prescribing in chronic kidney disease: A systematic review of prevalence, associated clinical outcomes and impact of interventions.Inappropriate Medication in Non-Hospitalized Patients With Renal Insufficiency: A Systematic Review.Community pharmacist intervention in patients with renal impairment.Prescription errors in geriatric patients can be avoided by means of a computerized physician order entry (CPOE).A simulation study of the interception of prescribing errors by clinical pharmacists in an acute hospital setting.Clinical decision support implemented with academic detailing improves prescribing of key renally cleared drugs in the hospital setting.Drug dosing in patients with renal insufficiency in a hospital setting using electronic prescribing and automated reporting of estimated glomerular filtration rate.Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.Improving prescribing safety in patients with renal insufficiency in the ambulatory setting: the Drug Renal Alert Pharmacy (DRAP) program.Drug prescribing in patients with renal impairment optimized by a computer-based, semi-automated system.Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: cockcroft-gault and modification of diet in renal disease.Concordance between modification of diet in renal disease, chronic kidney disease epidemiology collaboration and Cockcroft-Gault equations in patients with chronic kidney disease at St. Paul's hospital millennium medical college, Addis Ababa, EthiopDose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety.The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).Drug dosage adjustments according to renal function at hospital discharge.
P2860
Q28468296-A3FA36DE-20B9-4CD3-90DA-5FB2EB8B5778Q34566989-0EFA8572-2C5F-4FE9-A613-A08C2893B6C5Q34754405-8CF47289-6F60-40AA-98D5-5D0A08B37353Q36113855-8017A608-EAFB-4687-A10A-C5DA5E3AEEF2Q36169704-A72BAFBD-03D6-48FB-B7AB-652148A6E46BQ36522911-99BF0E23-B22B-4A25-A40E-1A01A9B2EB96Q36584160-475263AC-67CD-4CE4-AA09-88C460F18C07Q36969326-F820B849-883B-4A56-B76D-EDA738920378Q37249191-1E033E8B-06B9-4BCB-8779-EAE32D336545Q37314699-E9C0C74F-1AA1-4F31-BCD0-9D6AED847E47Q37353810-7B1A18A3-B035-4D2F-B8E4-D2E6670E6E75Q37879330-AFD2CDDC-948E-479C-A569-5C96A8B3CBE5Q38085223-31E54633-D204-414D-86A7-C3147C791CE9Q38262871-993D5573-78B9-4CFB-A1C4-A06F67C26986Q38560098-49759BFA-DAE8-4CFE-B771-1AE0A6C00A0DQ38672320-2AFFB691-8F44-4AD6-A62B-873993C449BEQ38679025-B51BC46F-823E-4AAB-90CA-5738236E1626Q38939930-D6EB17BC-7AEC-47F9-AC45-C5E7E6A7FA3BQ40524335-C1E9B396-44A4-48FF-B1B3-8A73AAAA989DQ40848474-2176A2E3-B105-4372-915E-CD1BD08E4B84Q41020531-7BD66A17-2216-4CBD-88C2-6500FC1EA120Q41314653-B9C75579-C08A-4AEB-B311-436287BD0B3EQ42234957-13CD929B-7191-4691-85E0-29DAD11BA003Q43272333-0BD14037-9BAB-47FE-9A5A-B4A7038E4235Q43654956-8A39E954-978C-485D-AAAE-71E87878061BQ43731434-44F06E57-2A65-4FDC-A954-3BA45621BE00Q46408018-D26603B1-B3AC-45DA-884C-1DAFE4AFD0AAQ47105484-9F020C4C-DF6E-4696-8A72-58F4DAEDFF1FQ47182019-B422D498-ADA1-4B0C-8B5A-1CBF819B4758Q48097465-C85DC514-642E-4660-A26A-25A1D60921C2Q53772903-F49ED941-571F-4653-B08A-9E1A09E3F045
P2860
Compliance with dosing guidelines in patients with chronic kidney disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Compliance with dosing guidelines in patients with chronic kidney disease.
@ast
Compliance with dosing guidelines in patients with chronic kidney disease.
@en
type
label
Compliance with dosing guidelines in patients with chronic kidney disease.
@ast
Compliance with dosing guidelines in patients with chronic kidney disease.
@en
prefLabel
Compliance with dosing guidelines in patients with chronic kidney disease.
@ast
Compliance with dosing guidelines in patients with chronic kidney disease.
@en
P2093
P2860
P356
P1476
Compliance with dosing guidelines in patients with chronic kidney disease.
@en
P2093
Charron L Long
David J Magid
David W Price
Marsha A Raebel
P2860
P304
P356
10.1345/APH.1D399
P407
P577
2004-03-30T00:00:00Z